Pharmacologic and clinical profile of dexamethasone intravitreal implant.

Expert review of clinical pharmacology

Volumn 5, Issue 6, 2012, Pages 629-647

  Robinson, Michael R ^a   Whitcup, Scott M ^b  

^a ALLERGAN INC   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; GLUCOCORTICOID;

ARTICLE; DRUG EFFECT; DRUG IMPLANT; HALF LIFE TIME; HUMAN; RETINA DISEASE; TIME; VISUAL ACUITY; VITREOUS BODY;

DEXAMETHASONE; DRUG IMPLANTS; GLUCOCORTICOIDS; HALF-LIFE; HUMANS; RETINAL DISEASES; TIME FACTORS; VISUAL ACUITY; VITREOUS BODY;

EID: 84877644275     PISSN: None     EISSN: 17512441     Source Type: Journal    
DOI: 10.1586/ecp.12.55     Document Type: Article

References (0)